[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637673":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":46,"collaborators":20,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":57,"minAge":58,"maxAge":20,"enrollmentInfo":59,"targetDuration":20,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":69,"overallStatus":30,"whyStopped":20,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Withings","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"All patients","EXPERIMENTAL","Patients consenting to participate to the study and compliant to the inclusion criteria",[13],"Device: Blood pressure measurement",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Blood pressure measurement","The patient will be measured alternatively with a reference mercury sphygmomanometer (four times) and the device under study (3 times)",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Inès Bedouda","CONTACT","0141460460","clinical-trials@withings.com",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":32,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"N2","RECRUITING","Yerevan","Armenia","0002","AM",{"type":36,"coordinates":37},"Point",[38,39],44.5126,40.17765,{"lat":39,"lon":38},[42],{"name":43,"role":24,"phone":44,"phoneExt":20,"email":45},"Parounak ZELVEIAN, Professor","374-10-530572","zelveian@hotmail.com",{"type":47,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100637673","clinical-validation-of-the-blood-pressure-measuring-device-withings-bpm-pro-2-in-pregnancy-and-pre-eclampsia-100637673",false,"NCT07595016","Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-Eclampsia","Clinical Validation Of The Brachial Blood Pressure Measuring Device Withings BPM Pro 2 According To \"The Universal Protocol For The Validation Of Blood Pressure Measuring Devices By The Association For The Advancement Of Medical Instrumentation \u002F European Society Of Hypertension \u002F International Organization For Standardization (AAMI\u002FESH\u002FISO) (And Its Amendment 1 (2020) And 2 (2024))\" In Pregnancy And Pre-Eclampsia","WIHYP-PW","Inclusion Criteria:\n\n* Patient older than 18 years;\n* Known pregnancy, in second or third trimester of pregnancy ( \\> 3 months);\n* Patient normotensive, hypertensive or in preeclampsia;\n* Patient who signed the informed consent form;\n* Patient followed-up at site (in-patient or out-patient);\n* Patient with arm circumference between 22 cm and 42 cm.\n\nExclusion Criteria:\n\n* Patient unable to give a consent or understand properly protocol information;\n* Patient suffering from arrhythmia;\n* Patient with poor quality of Korotkov sounds;\n* Patient for whom K5 sounds are absent;\n* Patient wearing an implantable electric medical device (pacemaker,…);\n* Patient with both upper arms suffering from open wound and\u002For damaged skin.",true,"ALL","18 Years",{"count":60,"type":61},45,"ESTIMATED","INTERVENTIONAL",[64],"NA","The aim of the study is to assess the accuracy of the automatic oscillometric BP measuring device at the brachial level, the WITHINGS BPM Pro 2, in pregnancy and pre-eclampsia",[67,68],"Hypertension","Pre-eclampsia",[70,71,72,73,74],"hypertension","blood pressure monitor","pregnancy","pre-eclampsia","validation","2026-06-01",{"date":77,"type":78},"2026-06-03","ACTUAL",{"date":80,"type":78},"2026-05-11",{"date":82,"type":61},"2026-09-30",{"name":5,"class":6},1]